Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $6.7 million.

  • Mainz Biomed's Non-Current Assets rose 1076.09% to $6.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $24.6 million, marking a year-over-year decrease of 751.91%. This contributed to the annual value of $5.4 million for FY2024, which is 1609.85% down from last year.
  • As of Q2 2025, Mainz Biomed's Non-Current Assets stood at $6.7 million, which was up 1076.09% from $5.4 million recorded in Q4 2024.
  • In the past 5 years, Mainz Biomed's Non-Current Assets ranged from a high of $7.2 million in Q1 2023 and a low of $431586.0 during Q4 2021
  • For the 5-year period, Mainz Biomed's Non-Current Assets averaged around $4.9 million, with its median value being $6.2 million (2023).
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 77877.79% in 2023, then crashed by 1609.85% in 2024.
  • Over the past 5 years, Mainz Biomed's Non-Current Assets (Quarter) stood at $431586.0 in 2021, then surged by 331.59% to $1.9 million in 2022, then surged by 245.16% to $6.4 million in 2023, then fell by 16.1% to $5.4 million in 2024, then rose by 24.52% to $6.7 million in 2025.
  • Its last three reported values are $6.7 million in Q2 2025, $5.4 million for Q4 2024, and $6.1 million during Q2 2024.